New York investigation may distract, cost UnitedHealth
Minneapolis Star Tribune, February 15, 2008
A day after New York's attorney general took aim at UnitedHealth Group's healthcare reimbursement procedures, the ultimate financial implications for the nation's largest insurer were yet to come into focus. But there is little doubt that Andrew Cuomo's probe has handed company executives a significant distraction and a bit of a black eye. Although some analysts believe UnitedHealth will continue to operate with minimal bottom-line effect during Cuomo's fledgling inquiry and expected lawsuit, the consensus is far from unanimous.
Most Viewed
Most Emailed
- 69% of Employers Plan to Offer Healthcare Coverage After 2014
- Primary Care Docs Average More Hospital Revenue Than Specialists
- Building a Better Healthcare Board
- CMS Seeks to 'Rapidly Reduce' Medicare Spending with $1B in Grants
- Q&A: Catholic Health Initiatives' New Senior VP for Capital Finance
- Quiet ORs Better for Patient Safety
- CMS Releases Hospital Pricing Data
- Hospital Pricing Data Dump Won't Hurt You, Yet
- Evidence-Based Practice and Nursing Research: Avoiding Confusion
- Telemedicine is Retail Health Clinics' Newest Tool
